As of 2025-09-16, the Intrinsic Value of Revolution Medicines Inc (RVMD) is -16.05 USD. This RVMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 46.20 USD, the upside of Revolution Medicines Inc is -134.74%.
Based on its market price of 46.20 USD and our intrinsic valuation, Revolution Medicines Inc (RVMD) is overvalued by 134.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.05 - -16.05 | -16.05 | -134.74% |
| P/E | (34.93) - (49.25) | (43.50) | -194.2% |
| DDM - Stable | (21.01) - (70.18) | (45.59) | -198.7% |
| DDM - Multi | (18.38) - (49.82) | (27.09) | -158.6% |
| Market Cap (mil) | 8,636.17 |
| Beta | 1.03 |
| Outstanding shares (mil) | 186.93 |
| Enterprise Value (mil) | 8,233.73 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.41% |
| Cost of Debt | 5.00% |
| WACC | 8.20% |